Cargando…
PRR15 deficiency facilitates malignant progression by mediating PI3K/Akt signaling and predicts clinical prognosis in triple-negative rather than non-triple-negative breast cancer
Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast neoplasms with a higher risk of recurrence and metastasis than non-TNBC. Nevertheless, the factors responsible for the differences in the malignant behavior between TNBC and non-TNBC are not fully explored. Proline rich 15...
Autores principales: | Guo, Fengzhu, Ma, Jialu, Li, Cong, Liu, Shuning, Wu, Weizheng, Li, Chunxiao, Wang, Jiani, Wang, Jinsong, Li, Zhijun, Zhai, Jingtong, Sun, Fangzhou, Zhou, Yantong, Guo, Changyuan, Qian, Haili, Xu, Binghe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113191/ https://www.ncbi.nlm.nih.gov/pubmed/37072408 http://dx.doi.org/10.1038/s41419-023-05746-8 |
Ejemplares similares
-
Prognostic Factors for Triple-Negative Breast Cancer with Residual Disease after Neoadjuvant Chemotherapy
por: Li, Zhijun, et al.
Publicado: (2023) -
Loss of TTC17 promotes breast cancer metastasis through RAP1/CDC42 signaling and sensitizes it to rapamycin and paclitaxel
por: Zhang, Jingyao, et al.
Publicado: (2023) -
Aldehyde dehydrogenase 1 (ALDH1) expression is an independent prognostic factor in triple negative breast cancer (TNBC)
por: Ma, Fei, et al.
Publicado: (2017) -
Extracellular matrix-derived mechanical force governs breast cancer cell stemness and quiescence transition through integrin-DDR signaling
por: Li, Cong, et al.
Publicado: (2023) -
Cytotoxic Lymphocyte-Related Gene Signature in Triple-Negative Breast Cancer
por: Han, Yiqun, et al.
Publicado: (2023)